Original Research
Published on 22 Jan 2024
The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

- 1,332 views












